GlaxoSmithKline
- Country
- 🇬🇧United Kingdom
- Ownership
- Public
- Established
- 1929-01-01
- Employees
- 70.2K
- Market Cap
- $90B
- Website
- http://www.gsk.com
- Introduction
GSK Plc is a healthcare company, which engages in the research, development, and manufacture of pharmaceutical medicines, vaccines, and consumer healthcare products. It operates through the Commercial Operations, and Research and Development segments. The Commercial Operations segment has three product groups of specialty medicines, vaccines, and general medicines. The company was founded in 1715 and is headquartered in Middlesex, the United Kingdom.
Long-term Efficacy and Safety of Subjects Approximately 3 Years After Priming With 2 Doses of GSK Bio's HRV Vaccine.
- Conditions
- Infections, Rotavirus
- Interventions
- Biological: Placebo (primary vaccination study)Biological: Rotarix (primary vaccination study)
- First Posted Date
- 2007-01-11
- Last Posted Date
- 2018-08-28
- Lead Sponsor
- GlaxoSmithKline
- Target Recruit Count
- 1613
- Registration Number
- NCT00420316
- Locations
- 🇫🇮
GSK Investigational Site, Vantaa, Finland
MDD POC Study GSK372475 Subjects Depressive Disease
- Conditions
- Depressive Disorder
- Interventions
- First Posted Date
- 2007-01-11
- Last Posted Date
- 2018-02-05
- Lead Sponsor
- GlaxoSmithKline
- Target Recruit Count
- 492
- Registration Number
- NCT00420641
- Locations
- 🇵🇱
GSK Investigational Site, Leszno, Poland
To Assess Safety, Reactogenicity & Immunogenicity of 2 Doses of GSK's Oral Human Rotavirus Vaccine in Pre-Term Infants
- Conditions
- Infections, Rotavirus
- Interventions
- Biological: Rotarix™Biological: Placebo
- First Posted Date
- 2007-01-11
- Last Posted Date
- 2018-06-08
- Lead Sponsor
- GlaxoSmithKline
- Target Recruit Count
- 1009
- Registration Number
- NCT00420745
- Locations
- 🇪🇸
GSK Investigational Site, Valladolid, Spain
SB-681323-Methotrexate Interaction Study
- Conditions
- Arthritis, Rheumatoid
- First Posted Date
- 2007-01-09
- Last Posted Date
- 2012-06-04
- Lead Sponsor
- GlaxoSmithKline
- Target Recruit Count
- 18
- Registration Number
- NCT00419809
- Locations
- 🇦🇺
GSK Investigational Site, Adelaide, Australia
Restless Legs Patient Study On Absorption, Distribution, Metabolism And Excretion Of Ropinirole And The Effect Of Food
- First Posted Date
- 2007-01-09
- Last Posted Date
- 2017-10-13
- Lead Sponsor
- GlaxoSmithKline
- Target Recruit Count
- 32
- Registration Number
- NCT00419692
- Locations
- 🇿🇦
GSK Investigational Site, George, South Africa
Investigating The Pharmacokinetics Of An Inhaled Dose Of A New Corticosteroid In Patients With Impaired Liver Function
- Conditions
- Asthma
- Interventions
- Drug: GW685698X
- First Posted Date
- 2007-01-08
- Last Posted Date
- 2017-11-06
- Lead Sponsor
- GlaxoSmithKline
- Target Recruit Count
- 20
- Registration Number
- NCT00419237
Study Of The Effects Of A New Antidepressant Therapy In Patients With Major Depressive Disorder (MDD)
- Conditions
- Depressive Disorder, Major
- First Posted Date
- 2006-12-19
- Last Posted Date
- 2016-10-28
- Lead Sponsor
- GlaxoSmithKline
- Target Recruit Count
- 348
- Registration Number
- NCT00413023
- Locations
- 🇸🇪
GSK Investigational Site, Solna, Sweden
Study to Assess Safety & Immunogenicity of GSK Biologicals' DTPa/Hib Vaccine vs Separate Administration of DTPa and Hib.
- Conditions
- TetanusDiphtheriaAcellular Pertussis
- First Posted Date
- 2006-12-19
- Last Posted Date
- 2018-06-06
- Lead Sponsor
- GlaxoSmithKline
- Target Recruit Count
- 660
- Registration Number
- NCT00412854
- Locations
- 🇨🇳
GSK Investigational Site, Wuzhou, China
Effects Of The Drug Ketoconazole On How The Body Handles The Drug SB773812
- First Posted Date
- 2006-12-15
- Last Posted Date
- 2017-08-03
- Lead Sponsor
- GlaxoSmithKline
- Target Recruit Count
- 36
- Registration Number
- NCT00411866
- Locations
- 🇬🇧
GSK Investigational Site, Dundee, United Kingdom
A Study Of GSK679586A When Infused Into Healthy And Mild Asthmatic Volunteers
- Conditions
- Asthma
- Interventions
- Drug: PlaceboDrug: GSK679586
- First Posted Date
- 2006-12-15
- Last Posted Date
- 2012-03-19
- Lead Sponsor
- GlaxoSmithKline
- Target Recruit Count
- 56
- Registration Number
- NCT00411814
- Locations
- 🇦🇺
GSK Investigational Site, Melbourne, Victoria, Australia